The result of the use of a salt suspension pneumococcus vaccine at Camp Upton was published by Cecil and Austin (37). A study of the agglutination and protective power of the serum of 42 persons vaccinated against pneumococcus types I, II and III demonstrated that a definite immune response could be secured to types I and II but not to type III. Twelve thousand five hundred and nineteen men were vaccinated at the camp, and most of the men received three or four inoculations at intervals of from five to seven days. The men were under observation for ten weeks, and during that time no cases of pneumonia of the three fixed types occurred among those who had received two or more injections. In a control of approximately 20,000 men there were 26 cases of pneumonia of types I, II and III. The incidence of pneumococcus type IV pneumonia was less among the vaccinated than among the unvaccinated groups. There were, however, 17 cases of pneumonia among the vaccinated men, compared to 173 cases of pneumonia among the controls. The annual pneumonia death rate for vaccinated groups in the army was 0.83 per one thousand, and for unvaccinated groups was 12.8. Fennell reported the use of pneumo-lipovaccine in Washington during the influenza epidemic, but the number of cases cited by him were too small to permit of definite conclusions. His results appeared favorable. Cecil and Vaughan (37a) reported on the results of vaccination with pneumo-lipovaccine at Camp Wheeler; 13,460 men, comprising 80 per cent. of the camp, were inoculated. Most of these men were under observation for 2 or 3 months after vaccination, and there occurred among them 32 cases of pneumococcus types I, II and III pneumonia. In one-fifth of the camp which was not vaccinated there occurred 43 cases of pneumonia. They observed that influenza caused a marked reduction in the resistance to pneumonia among vaccinated as well as non-vaccinated men. Of 155 cases of pneumonia of all types, which developed one week or more after vaccination, 133 were secondary to influenza. The death rate among vaccinated men one week or more after vaccination was 12.2 per cent., whereas the death rate for 327 cases of all types of pneumonia which occurred among unvaccinated groups was 22.3 per cent. The death rate for primary pneumonia among vaccinated groups was 11.9 per cent., and among unvaccinated 31.8 per cent. It was found that protective bodies do not begin to appear in the serum after lipovaccines are given until the eighth day after the injection. Twenty-four cases of pneumonia occurred in the first week after vaccination. In their conclusions Cecil and Vaughan state that there was no evidence whatever that pneumococcus vaccine predisposed the individual, even temporarily, toward either pneumococcus or streptococcus pneumonia. Most of the reactions after vaccination were mild, but one disagreeable feature was that in a certain percentage there persisted a small fluctuating mass at the site